Hemolymphangioma is a benign condition that may be a slowly growing cyst over a period of time or a tumor that grows aggressively but has no invasive capacity[6]. Therefore, hemangiolymangioma usually do not have typical clinical manifestations. In this case, the patient's symptoms of upper abdominal distension and low back pain may have been caused by compression from the large tumor. Preoperative diagnosis and evaluation by imaging are essential, and these lesions should be differentiated from ganglioneuroma, myelolipoma, epidermoid cyst, lymphangioma, and cystic teratoma. The typical appearance of hemolymphangioma is cystic or solid. The cystic part may be due to rupture and fusion of the vascular cavity, and the solid part may be residual compressed vascular tissue[7]. A significantly shortened T1-weighted MRI may indicate that the cystic mass contained old blood[8].
In this study, we used the PubMed database to review the literature up to December 2023, and there were only 3 reports of hemolymphangioma occurring in the retroperitoneal space. French scholars first reported a case of infectious retroperitoneal hemolymphangioma with venomusculoskeletal hypertrophy syndrome in 1983. We did not have the details of the case[9]. In 1987, Japanese researchers reported a case of giant retroperitoneal hemolymphangioma and discussed its appearance on MRI. In addition, factor VIII related antigen staining was also used to differentiate lymphatic vessels from blood vessels[8]. Another Japanese group reported a 68-year-old man with retroperitoneal hemolymphangioma in 2018[1].
As shown in Table 1, all four patients were male, three had large tumors, and the volume of tumors in our study was the largest. We speculate that because there are no special symptoms in the early stage of hemolymphangioma originating from the retroperitoneal space, patients will pay attention to this disease when the tumor volume increases which can lead to compression symptoms or signs of a large mass. Because hemolymphangioma is rare, various imaging methods are often needed for diagnosis and differential diagnosis before surgery, among which MRI is very helpful for determining the nature of the content of the mass. When the T1 time is significantly shortened, hemolymphangioma should be considered. Although hemolymphangioma is a benign tumor, surgical resection is recommended to avoid further aggressive tumor growth or recurrence, and surgical resection was performed for all 4 patients. The final diagnosis depends on the pathological results. Immunohistochemical staining for D2-40, CD31 and CD34 was often positive.
Table 1
Characteristics of four patients with retroperitoneal hemolymphangioma
| Sex | Age | Size | Preoperative diagnosis | Treatment | Prognosis |
1 | M | 29year | 22×9cm | none | tumor resection | none |
2 | M | 17year | 25×15×7cm | lymphangioma with bleeding | tumor resection | none |
3 | M | 68year | 40×32mm | liposarcoma or lymphoma | tumor resection | no recurrence |
4 | M | 37year | 20.0×16.3×31.3cm | lymphangioma | tumor resection | no recurrence |